SIR -Your recent publication of James Watson's sequenced genome (D. A. Wheeler at al. Nature 452, 872-876; 2008) makes for fascinating reading -that is, for anyone who has enough knowledge of genetics and biology to interpret it. Peel away the single nucleotide polymorphisms (SNPs), the copynumber variations and the indels, and the core message seems, well, empty. After an unexpected rise of pertussis (whooping cough) cases in the 1990s, Britain revamped its system to reward general practitioners for fully immunizing all children on their lists, paying a bonus to those who reached 90% then, a few years later, 95%. This system did not exclude from the denominator the small number of patients with good medical reasons against receiving vaccine.
Why the societal strategy? No vaccine is fully effective in everyone who receives it. Only 'herd immunity' can protect those in whom a vaccine does not stimulate protective immunity. Population health therefore improves where policies support full coverage of the population. Such policies create a culture in which health authorities educate doctors, parents and patients about the societal goals as well as individual contraindications.
Good immunization policies balance the risks of vaccines against the benefits. All vaccines, usually given to healthy people, pose some small risk. Good medical reasons do occasionally exist for some people to avoid some vaccines. Britain understood this, and designed its policy to avoid incentives for doctors to vaccinate in such situations. 503; 2008) , that good science depends on good ideas and not good intentions, is unlikely to make much difference to politicians anxious for public favour or to scientists anxious for money.
As you declared more than 15 years ago (Nature 360, 13; 1992), "the increasingly crass politicization of biomedical research looms as something of a menace, for it presupposes first that more money for more scientists is a way to medical salvation, and second that well-meaning groups of citizenactivists and professional lobbyists have a scientifically useful role in deciding where research money should be directed. There is, alas, inadequate evidence to support either proposition." Technology can be bought, but science depends first on ideas and luck, to which the link is more imprecise.
In that News & Views article, you give four examples where politics threatened to derail science. One of them -five years before the Clinton promise mentioned in the Editorial (it is fascinating just how many breakthroughs are promised "within a decade") -was of the US National Institutes of Health and Food and Drug Administration trying to stop lobbyist-driven testing of an unproven AIDS vaccine. 
